Brief communication: Morphoproteomic portrait of the mTOR pathway in mesenchymal chondrosarcoma

Annals of Clinical and Laboratory Science

Volumn 34, Issue 4, 2004, Pages 397-399

  Brown, Robert E ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

Mesenchymal chondrosarcoma; Morphoproteomics; MTOR pathway

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN; PROTEIN KINASE; TUMOR MARKER;

ARTICLE; CHONDROSARCOMA; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESENCHYME CHONDROSARCOMA; MORPHOMETRICS; MORPHOPROTEOMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PROTEIN TRANSPORT; PROTEOMICS; SIGNAL TRANSDUCTION; TUMOR GROWTH; CARTILAGE CELL; METABOLISM; METHODOLOGY; PATHOLOGY; SOFT TISSUE TUMOR;

MAMMALIA;

CHONDROCYTES; CHONDROSARCOMA, MESENCHYMAL; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN KINASES; PROTEOMICS; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 11144257061     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Brown RE, Boyle JL. Mesenchymal chondrosarcoma: molecular characterization by a proteomic approach, with morphogenic and therapeutic implications. Ann Clin Lab Sci 2003;33:131-141.
2. Oh CD, Kim SJ, Ju JW, Song WK, Kim JH, Yoo YJ, Chun JS. Immunosuppressant rapamycin inhibits protein kinase C alpha and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis. Eur J Pharmacol 2001;427:175-185.
3. Ishizuka T, Sakata N, Johnson GL, Gelfand EW, Terada N. Rapamycin potentiates dexamethasone-induced apoptosis and inhibits JNK activity in lymphoblastoid cells. Biochem Biophys Res Commun 1997;230:386-391.
4. Panwalkar A, Verstovsek S, Giles FJ. Mammalian target of rapamycin inhibition as therapy for hematologic malignancies. Cancer 2004;100:657-666.
5. Peralba JM, DeGraffenried L, Friedrichs W, Fulcher L, Grunwald V, Weiss G, Hidalgo M. Pharmacodynamic evaluation of CCI-779, an inhibitor of mTOR in cancer patients. Clin Cancer Res 2003;9:2887-2892.
6. Chen QP, Giannobile WV. Adenoviral gene transfer of PDGF downregulates gas gene product PDGF alphaR and prolongs ERK and Akt/PKB activation. Am J Physiol Cell Physiol 2002;282:C538-544.
7. Baron W, Decker L, Colognato H, Constant C. Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains. Current Biology 2003;13:151-155.
8. Tsutsumi N, Yonemitsu Y, Shikada Y, Onimaru M, Tanii M, Okana S, Kaneko K, Hasegawa M, Hashizume M, Maehara Y, Sueishi K. Essential role of PDGFR-alpha-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFR-alpha during angiogenesis. Circulation Research 2004;94:1186-1194.